Study of Vilazodone to Treat Social Anxiety Disorder

Status unconfirmed · Not applicable · Has a placebo group

Conditions studied: Social Anxiety Disorder

In brief

The purpose of this study is to determine whether Vilazodone is effective in the treatment of symptoms of Social Anxiety Disorder among adults.

Key facts

Study ID

NCT01712321

Run by

The Medical Research Network

People needed

30

Starts

2012-10-01

Expected to finish

2014-04-01

Last updated by the study team

2014-01-20

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of Social Anxiety Disorder, generalized subtype
• LSAS total score of 70 at visits 1 and 2

You may not qualify if…

• Lifetime history of Bipolar disorder or Schizophrenia
• Current suicidal risk
• Current unstable medical condition

Where it is running

• The Medical Research Network, LLC — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.